Financials
Income statement
Fiscal date | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
---|---|---|---|---|
Total reported revenue | 13.1B | 15.3B | 13.5B | 13.7B |
Cost of revenue | 1.6B | 1.5B | 1.5B | 1.5B |
Gross profit | 11.6B | 13.7B | 12.0B | 12.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 3.5B | 4.0B | 2.9B | 3.6B |
Non operating interest income | ||||
Income | 1.9M | 1.2M | 1.1M | 1.2M |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 3.3B | 4.1B | 2.3B | 3.6B |
Tax provision | 1.0B | 1.3B | 129.6M | 1.1B |
Net income | 2.2B | 2.8B | 2.2B | 2.5B |
Basic EPS | — | 51.4 | — | — |
Diluted EPS | — | 51.4 | — | — |
Basic average shares | — | 54.5M | — | — |
Diluted average shares | — | 54.5M | — | — |
EBITDA | 4.5B | 4.8B | 4.3B | 4.3B |
Net income from continuing op. | 3.3B | 4.1B | 2.3B | 3.6B |
Minority interests | 65K | -496K | 2.6M | 169K |
Preferred stock dividends | 0 | 0 | 0 | 0 |